Replimune Group, Inc.
NASDAQ:REPLBiotechnology
Healthcare
$19.81 +1.85%
+$0.19 today
- Market cap
- $1.88B
- Beta
- 0.91
- P/E (TTM)
- -3.0
- EPS (TTM)
- -$3.42
52W Low $1.50High $13.24
Volume 2.13M
Average 7.51M
Price history
Replimune Group, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+120.36%
Period high
$23.28
Period low
$1.70
Latest
$19.81
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| SC 13G | Nov 10, 2026 | Nov 10, 2026 | |
| 4 | Nov 10, 2026 | Nov 10, 2026 | |
| SC 13G/A | Nov 9, 2026 | Nov 9, 2026 | |
| 10-Q/A | Nov 6, 2026 | Nov 6, 2026 | |
| 4 | Nov 3, 2026 | Nov 3, 2026 | |
| 8-K | Oct 28, 2026 | Oct 28, 2026 | |
| 10-Q | Oct 28, 2026 | Oct 28, 2026 | |
| 8-K | Sep 16, 2026 | Sep 16, 2026 | |
| 4 | Aug 24, 2026 | Aug 24, 2026 | |
| 4 | Aug 19, 2026 | Aug 19, 2026 | |
| 8-K | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| S-3ASR | Aug 14, 2026 | Aug 14, 2026 | |
| 10-Q | Aug 14, 2026 | Aug 14, 2026 | |
| 4 | Aug 12, 2026 | Aug 12, 2026 |
Competitors
Who does Replimune Group, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about REPL's filings, answered from its disclosures.
What is the latest REPL filing?
The latest filing shown is SC 13G dated Nov 10, 2026.
How many recent filings does REPL have?
Intrinsic Alpha currently shows 20 recent filings for REPL.
Continue the stock analysis
Jump to another research area for this company.